|
GLS expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.47469863782158E-11 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.68390000224272E-08 |
| Normal-vs-Stage2 |
3.141700E-03 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
1.482030E-02 |
| Stage1-vs-Stage2 |
5.454800E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
2.911200E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
4.536600E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.25069995973826E-09 |
| Normal-vs-AfricanAmerican |
2.053200E-01 |
| Normal-vs-Asian |
1.550230E-01 |
| Caucasian-vs-AfricanAmerican |
5.910000E-01 |
| Caucasian-vs-Asian |
3.863200E-01 |
| AfricanAmerican-vs-Asian |
9.067600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.98230000000499E-05 |
| Normal-vs-Female |
9.66909999955412E-07 |
| Male-vs-Female |
7.912000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.720300E-03 |
| Normal-vs-Extreme_Weight |
4.07380000000401E-06 |
| Normal-vs-Obese |
1.250470E-02 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
6.812800E-01 |
| Normal_Weight-vs-Obese |
7.273000E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
4.242600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.518600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.016630E-04 |
| Normal-vs-Age(61-80Yrs) |
4.99510000029346E-08 |
| Normal-vs-Age(81-100Yrs) |
4.692600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.802600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.344000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.290400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.564000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.673180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.543240E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
7.331800E-02 |
| Normal-vs-Grade 3 |
8.146400E-02 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
7.995600E-01 |
| Grade 2-vs-Grade 4 |
7.331800E-02 |
| Grade 3-vs-Grade 4 |
8.146400E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.34190000514678E-09 |
| Normal-vs-N1 |
3.944300E-02 |
| N0-vs-N1 |
2.494600E-01 |
|
|
|
GLS expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.47469863782158E-11 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.68390000224272E-08 |
| Normal-vs-Stage2 |
3.141700E-03 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
1.482030E-02 |
| Stage1-vs-Stage2 |
5.454800E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
2.911200E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
4.536600E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.25069995973826E-09 |
| Normal-vs-AfricanAmerican |
2.053200E-01 |
| Normal-vs-Asian |
1.550230E-01 |
| Caucasian-vs-AfricanAmerican |
5.910000E-01 |
| Caucasian-vs-Asian |
3.863200E-01 |
| AfricanAmerican-vs-Asian |
9.067600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.98230000000499E-05 |
| Normal-vs-Female |
9.66909999955412E-07 |
| Male-vs-Female |
7.912000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.720300E-03 |
| Normal-vs-Extreme_Weight |
4.07380000000401E-06 |
| Normal-vs-Obese |
1.250470E-02 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
6.812800E-01 |
| Normal_Weight-vs-Obese |
7.273000E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
4.242600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.518600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.016630E-04 |
| Normal-vs-Age(61-80Yrs) |
4.99510000029346E-08 |
| Normal-vs-Age(81-100Yrs) |
4.692600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.802600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.344000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.290400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.564000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.673180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.543240E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
7.331800E-02 |
| Normal-vs-Grade 3 |
8.146400E-02 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
7.995600E-01 |
| Grade 2-vs-Grade 4 |
7.331800E-02 |
| Grade 3-vs-Grade 4 |
8.146400E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.34190000514678E-09 |
| Normal-vs-N1 |
3.944300E-02 |
| N0-vs-N1 |
2.494600E-01 |
|
|
